AST podcasts and recordings
Podcasts
March 22, 2010
In this podcast, Dr. Randall Sung, Associate Professor of Surgery and Surgical Director of the Kidney and Kidney Pancreas Transplant Program at the University of Michigan Medical School, discusses transplant outcomes of organs procured from donors after cardiac death. Dr. Sung discusses the details involved in the definition of donation after cardiac death, donor management and transplant outcomes as well as ethical issues associated with this modality. This podcast also provides practical, up-to-date information and advice to physicians who may have questions about the advantages and disadvantages of transplantation of organs from donors after cardiac death, and would like to counsel their transplant candidates about accepting organs procured from these donors.
December 31, 2009
Dr. George Mazariegos, Chief of Pediatric Transplantation and Liver Transplant Surgeon at Children's Hospital of Pittsburgh, and Professor of Surgery and Critical Care Medicine at University of Pittsburgh, discusses the challenges and current outcomes of neonatal liver transplantation. He reviews the diseases commonly leading to liver failure in the neonatal period and the unique considerations and challenges while awaiting organ availability. He also discusses the current medical and surgical outcomes after liver transplantation in neonates in 2010 including the outcomes with neonatal and infant donors, and other novel treatment alternatives in this challenging patient population.
December 18, 2009
Dr. Lisa McDevitt, Transplant Pharmacist at Tufts Medical Center and Assistant Professor at Tufts School of Medicine, discusses the unique issue regarding insurance coverage of immunosuppressive medications. She describes the differences in coverage offered by Medicare B and D as well as private insurance. In addition, the utilization of patient assistance programs and private grants are reviewed.
December 17, 2009
Dr. Patricia Harren, Clinical Director of the Pediatric Transplant Institute at Columbia University, discusses strategies to transition pediatric patients to the adult transplant team. Working with patients and their families in a team approach to prepare them with the necessary knowledge and skills to advocate for themselves and maintain continued health promoting behaviors allows for a smoother, successful transition.
December 17, 2009
Dr. Roslyn Mannon, Professor of Medicine and Surgery, and Director of Transplantation Research at the University of Alabama presents, a thorough discussion of the relevant issues in maligancy detection, diagnosis and management in patients with kidney transplants, the role of specific immunosuppression in patients with malignancies and gives guidelines for the waitlisting of patients with prior malignancies. The listener of this podcast will have up-to-date approaches to the pathophysiology of cancer as well as strategies for better detection and treatment in their kidney transplant patients.
December 17, 2009
In this podcast, Dr. Michelle Josephson, Professor of Medicine and Director of Transplantation Medicine at the University of Chicago, discusses Bone Disease in transplant recipients. She emphasizes the importance of understanding the pathophysiology of bone disease and discusses the current screening and treatment recommendations as well as the most current KDIGO recommendations. This podcast provides practical, up-to-date information and advice for physicians about how to diagnose and treat bone disease in the transplant patient population.
December 14, 2009
Ms. Lisa Coscia, Senior Transplant Registry Research Coordinator, National Transplantation Pregnancy Registry (NTPR) at Thomas Jefferson University, describes the National Transplantation Pregnancy Registry (NTPR), its establishment, methods and process. She encourages all health care professional or transplant recipient to call the NTPR with any questions regarding pregnancy after transplantation.
December 07, 2009
Dr. Eric Tichy, from the Yale-New Haven Transplantation Center, interviews Dr. Nicole Weimert, Clinical Specialist in Solid Organ Transplantation Medical University of South Carolina and Assistant Professor at the South Carolina College of Pharmacy. Dr. Weimert discusses the roles that clinical pharmacists play in transplantation. She focuses on the typical activities of a transplant pharmacist on the patient care team, discusses the education pharmacists provide to patients and staff and describes the impact pharmacists have had in the field of transplantation.
September 24, 2009
In this podcast, Dr. Marian Michaels, Professor of Pediatrics and Surgery at Children's Hospital of Pittsburgh, discusses the novel H1N1 influenza virus and what it means to transplant patients and health care workers. She discusses the origin and epidemiology of this new virus and provides practical guidance on diagnosis, prevention and treatment of this virus as it pertains to transplant patients.
August 25, 2009
In this podcast, Dr. Joren Madsen, Professor of Surgery at Harvard Medical School, Director of the Transplant Center and Section Chief in Cardiac Surgery at the Massachusetts General Hospital and current President of the AST, describes the role of NK cells in both innate and adaptive immunity. He describes recent research delineating the role of NK cells in allograft rejection and tolerance, and speculates about targeting NK cells therapeutically.
Pages
Podcasts
In this podcast, Dr. Randall Sung, Associate Professor of Surgery and Surgical Director of the Kidney and Kidney Pancreas Transplant Program at the University of Michigan Medical School, discusses transplant outcomes of organs procured from donors after cardiac death. Dr. Sung discusses the details involved in the definition of donation after cardiac death, donor management and transplant outcomes as well as ethical issues associated with this modality. This podcast also provides practical, up-to-date information and advice to physicians who may have questions about the advantages and disadvantages of transplantation of organs from donors after cardiac death, and would like to counsel their transplant candidates about accepting organs procured from these donors.
Dr. George Mazariegos, Chief of Pediatric Transplantation and Liver Transplant Surgeon at Children's Hospital of Pittsburgh, and Professor of Surgery and Critical Care Medicine at University of Pittsburgh, discusses the challenges and current outcomes of neonatal liver transplantation. He reviews the diseases commonly leading to liver failure in the neonatal period and the unique considerations and challenges while awaiting organ availability. He also discusses the current medical and surgical outcomes after liver transplantation in neonates in 2010 including the outcomes with neonatal and infant donors, and other novel treatment alternatives in this challenging patient population.
Dr. Lisa McDevitt, Transplant Pharmacist at Tufts Medical Center and Assistant Professor at Tufts School of Medicine, discusses the unique issue regarding insurance coverage of immunosuppressive medications. She describes the differences in coverage offered by Medicare B and D as well as private insurance. In addition, the utilization of patient assistance programs and private grants are reviewed.
Dr. Patricia Harren, Clinical Director of the Pediatric Transplant Institute at Columbia University, discusses strategies to transition pediatric patients to the adult transplant team. Working with patients and their families in a team approach to prepare them with the necessary knowledge and skills to advocate for themselves and maintain continued health promoting behaviors allows for a smoother, successful transition.
Dr. Roslyn Mannon, Professor of Medicine and Surgery, and Director of Transplantation Research at the University of Alabama presents, a thorough discussion of the relevant issues in maligancy detection, diagnosis and management in patients with kidney transplants, the role of specific immunosuppression in patients with malignancies and gives guidelines for the waitlisting of patients with prior malignancies. The listener of this podcast will have up-to-date approaches to the pathophysiology of cancer as well as strategies for better detection and treatment in their kidney transplant patients.
In this podcast, Dr. Michelle Josephson, Professor of Medicine and Director of Transplantation Medicine at the University of Chicago, discusses Bone Disease in transplant recipients. She emphasizes the importance of understanding the pathophysiology of bone disease and discusses the current screening and treatment recommendations as well as the most current KDIGO recommendations. This podcast provides practical, up-to-date information and advice for physicians about how to diagnose and treat bone disease in the transplant patient population.
Ms. Lisa Coscia, Senior Transplant Registry Research Coordinator, National Transplantation Pregnancy Registry (NTPR) at Thomas Jefferson University, describes the National Transplantation Pregnancy Registry (NTPR), its establishment, methods and process. She encourages all health care professional or transplant recipient to call the NTPR with any questions regarding pregnancy after transplantation.
Dr. Eric Tichy, from the Yale-New Haven Transplantation Center, interviews Dr. Nicole Weimert, Clinical Specialist in Solid Organ Transplantation Medical University of South Carolina and Assistant Professor at the South Carolina College of Pharmacy. Dr. Weimert discusses the roles that clinical pharmacists play in transplantation. She focuses on the typical activities of a transplant pharmacist on the patient care team, discusses the education pharmacists provide to patients and staff and describes the impact pharmacists have had in the field of transplantation.
In this podcast, Dr. Marian Michaels, Professor of Pediatrics and Surgery at Children's Hospital of Pittsburgh, discusses the novel H1N1 influenza virus and what it means to transplant patients and health care workers. She discusses the origin and epidemiology of this new virus and provides practical guidance on diagnosis, prevention and treatment of this virus as it pertains to transplant patients.
In this podcast, Dr. Joren Madsen, Professor of Surgery at Harvard Medical School, Director of the Transplant Center and Section Chief in Cardiac Surgery at the Massachusetts General Hospital and current President of the AST, describes the role of NK cells in both innate and adaptive immunity. He describes recent research delineating the role of NK cells in allograft rejection and tolerance, and speculates about targeting NK cells therapeutically.
Pages
Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.